| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
| RAR-related orphan receptor gamma | 9 | 0 | 0 | 9 |
| GLI family zinc finger 3 | 14 | 0 | 0 | 14 |
| AR protein | 16 | 0 | 0 | 16 |
| aldehyde dehydrogenase 1 family, member A1 | 8 | 0 | 0 | 8 |
| retinoic acid nuclear receptor alpha variant 1 | 8 | 0 | 0 | 8 |
| retinoid X nuclear receptor alpha | 9 | 0 | 0 | 9 |
| estrogen nuclear receptor alpha | 17 | 0 | 0 | 17 |
| peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 11 | 0 | 0 | 11 |
| activating transcription factor 6 | 3 | 0 | 0 | 3 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
| Histone H2A.x | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| heat shock protein beta-1 | 2 | 0 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 7 | 0 | 0 | 7 |
| lamin isoform A-delta10 | 8 | 0 | 0 | 8 |
| Voltage-dependent calcium channel gamma-2 subunit | 5 | 0 | 0 | 5 |
| Glutamate receptor 2 | 5 | 0 | 0 | 5 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 7 | 0 | 0 | 7 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 7 | 0 | 0 | 7 |
| glucocorticoid receptor [Homo sapiens] | 13 | 0 | 0 | 13 |
| G | 6 | 0 | 0 | 6 |
| thyroid hormone receptor beta isoform 2 | 7 | 0 | 0 | 7 |
| ATP-binding cassette sub-family C member 3 | 0 | 12 | 0 | 12 |
| Multidrug resistance-associated protein 4 | 0 | 12 | 0 | 12 |
| Bile salt export pump | 0 | 17 | 0 | 17 |
| Interferon beta | 10 | 0 | 0 | 10 |
| HLA class I histocompatibility antigen, B alpha chain | 6 | 0 | 0 | 6 |
| Aromatase | 0 | 7 | 0 | 7 |
| Cytochrome P450 2C9 | 0 | 5 | 0 | 6 |
| Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 3 |
| Spike glycoprotein | 6 | 0 | 1 | 7 |
| Inositol hexakisphosphate kinase 1 | 6 | 0 | 0 | 6 |
| Canalicular multispecific organic anion transporter 1 | 0 | 13 | 0 | 13 |
| cytochrome P450 2C9, partial | 6 | 0 | 0 | 6 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| thioredoxin reductase | 8 | 0 | 0 | 8 |
| phosphopantetheinyl transferase | 5 | 0 | 0 | 5 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| GLS protein | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| euchromatic histone-lysine N-methyltransferase 2 | 10 | 0 | 0 | 10 |
| cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
| chromobox protein homolog 1 | 9 | 0 | 0 | 9 |
| flap endonuclease 1 | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 4 | 0 | 0 | 4 |
| muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
| lethal factor (plasmid) | 3 | 0 | 0 | 3 |
| Cytochrome P450 3A4 | 0 | 6 | 0 | 9 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
| Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 7 | 0 | 0 | 7 |
| Chain A, Ferritin light chain | 5 | 0 | 0 | 5 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| USP1 protein, partial | 7 | 0 | 0 | 7 |
| PPM1D protein | 4 | 0 | 0 | 4 |
| Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
| geminin | 12 | 0 | 0 | 12 |
| peripheral myelin protein 22 | 5 | 0 | 0 | 5 |
| Vitamin D-binding protein | 0 | 0 | 1 | 1 |
| Cytochrome P450 1A2 | 0 | 4 | 0 | 5 |
| Androgen receptor | 0 | 5 | 2 | 7 |
| Cytochrome P450 2D6 | 0 | 4 | 0 | 4 |
| Vitamin D3 receptor | 0 | 2 | 4 | 9 |
| Vitamin D3 receptor | 0 | 1 | 1 | 3 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 1 | 1 |
| Cytochrome P450 2C19 | 0 | 3 | 0 | 3 |
| Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 0 | 2 | 2 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 1 | 1 | 2 |
| Transporter | 0 | 1 | 0 | 1 |
| Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
| Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| Luciferase | 2 | 0 | 0 | 2 |
| interleukin 8 | 3 | 0 | 0 | 3 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| farnesoid X nuclear receptor | 6 | 0 | 0 | 6 |
| pregnane X nuclear receptor | 10 | 0 | 0 | 10 |
| peroxisome proliferator activated receptor gamma | 9 | 0 | 0 | 9 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 5 | 0 | 0 | 5 |
| vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
| DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
| survival motor neuron protein isoform d | 4 | 0 | 0 | 4 |
| cytochrome P450 3A4 isoform 1 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit pi | 8 | 0 | 0 | 8 |
| Cellular tumor antigen p53 | 11 | 0 | 0 | 11 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit delta | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 8 | 0 | 0 | 8 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 8 | 0 | 0 | 8 |
| Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 8 | 0 | 0 | 8 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| GABA theta subunit | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit epsilon | 8 | 0 | 0 | 8 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| ATAD5 protein, partial | 4 | 0 | 0 | 4 |
| GALC protein | 5 | 0 | 0 | 5 |
| TDP1 protein | 11 | 0 | 0 | 11 |
| estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 3 | 6 | 0 | 0 | 6 |
| progesterone receptor | 7 | 0 | 0 | 7 |
| nonstructural protein 1 | 3 | 0 | 0 | 3 |
| estrogen-related nuclear receptor alpha | 8 | 0 | 0 | 8 |
| arylsulfatase A | 3 | 0 | 0 | 3 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
| Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 8 | 3 | 13 |
| Sex hormone-binding globulin | 0 | 0 | 2 | 2 |
| Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
| Steryl-sulfatase | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 2 | 0 | 3 |
| Androgen receptor | 0 | 9 | 0 | 9 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| Mu-type opioid receptor | 0 | 1 | 1 | 2 |
| Alpha-synuclein | 2 | 1 | 0 | 3 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 2 |
| Mu-type opioid receptor | 0 | 0 | 1 | 1 |
| Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
| TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
| Cytochrome P450 1B1 | 0 | 3 | 0 | 3 |
| Estrogen receptor beta | 0 | 6 | 3 | 10 |
| Ghrelin O-acyltransferase | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
| Chain A, Uracil Phosphoribosyltransferase | 0 | 0 | 1 | 1 |
| Chain B, Uracil Phosphoribosyltransferase | 0 | 0 | 1 | 1 |
| Chain C, Uracil Phosphoribosyltransferase | 0 | 0 | 1 | 1 |
| 67.9K protein | 2 | 0 | 0 | 2 |
| 2-dehydropantoate 2-reductase | 0 | 0 | 1 | 1 |
| Ras-related protein Rab-7a | 0 | 0 | 1 | 1 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 | 0 | 2 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
| EWS/FLI fusion protein | 5 | 0 | 0 | 5 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 4 | 0 | 0 | 4 |
| glp-1 receptor, partial | 3 | 0 | 0 | 3 |
| SMAD family member 2 | 3 | 0 | 0 | 3 |
| SMAD family member 3 | 3 | 0 | 0 | 3 |
| IDH1 | 5 | 0 | 0 | 5 |
| aryl hydrocarbon receptor | 4 | 0 | 0 | 4 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 1 | 1 | 2 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 2 |
| Mast/stem cell growth factor receptor Kit | 0 | 1 | 1 | 2 |
| Breakpoint cluster region protein | 0 | 0 | 1 | 1 |
| Platelet-derived growth factor receptor alpha | 0 | 1 | 1 | 2 |
| Cytochrome P450 3A5 | 0 | 1 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 5 | 0 | 0 | 5 |
| Ataxin-2 | 5 | 0 | 0 | 5 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 4 | 0 | 0 | 4 |
| Cytochrome P450 1A1 | 0 | 3 | 0 | 3 |
| runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
| core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 3 | 0 | 3 |
| Cytochrome P450 11B1, mitochondrial | 0 | 2 | 0 | 2 |
| Cytochrome P450 11B2, mitochondrial | 0 | 2 | 0 | 2 |
| chaperonin-containing TCP-1 beta subunit homolog | 2 | 0 | 0 | 2 |
| Synaptic vesicle glycoprotein 2A | 0 | 2 | 0 | 2 |
| pregnane X receptor | 1 | 0 | 0 | 1 |
| PINK1 | 1 | 0 | 0 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Glucocorticoid receptor | 0 | 6 | 2 | 13 |
| Progesterone receptor | 0 | 5 | 1 | 7 |
| Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
| Mineralocorticoid receptor | 0 | 3 | 1 | 4 |
| Androgen receptor | 0 | 0 | 1 | 1 |
| Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
| Histamine H2 receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 1B | 0 | 3 | 0 | 3 |
| Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
| Chain A, 2-oxoglutarate Oxygenase | 4 | 0 | 0 | 4 |
| ClpP | 1 | 0 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| caspase-3 | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
| Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
| Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
| bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
| L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 19 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| Vpr | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| Hsf1 protein | 0 | 0 | 1 | 2 |
| luciferase | 0 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 1 | 2 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Stromelysin-1 | 0 | 0 | 1 | 1 |
| Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
| Estrogen receptor | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
| Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 2 | 0 | 2 |
| Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
| Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
| Chain A, CES1 protein | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| polyprotein | 1 | 0 | 0 | 1 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Serine/threonine-protein kinase D3 | 0 | 1 | 1 | 2 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Lysosomal acid glucosylceramidase | 0 | 0 | 1 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Integrin beta-3 | 1 | 0 | 0 | 1 |
| Protein kinase C gamma type | 0 | 2 | 1 | 3 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| Protein kinase C beta type | 0 | 2 | 1 | 3 |
| Estrogen receptor | 0 | 0 | 1 | 2 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Procathepsin L | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 1 | 3 |
| Integrin alpha-IIb | 1 | 0 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Protein kinase C delta type | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
| Protein kinase C zeta type | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Adenosine receptor A3 | 0 | 2 | 0 | 2 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
| Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
| Protein kinase C alpha type | 0 | 2 | 1 | 3 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Protein kinase C eta type | 0 | 1 | 1 | 2 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 2 | 0 | 2 |
| B2 bradykinin receptor | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Protein kinase C iota type | 0 | 1 | 1 | 2 |
| Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
| Histamine H2 receptor | 1 | 0 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
| Estrogen-related receptor gamma | 0 | 1 | 0 | 1 |
| Protein kinase C gamma type | 0 | 1 | 0 | 1 |
| Protein kinase C beta type | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Protein kinase C epsilon type | 0 | 2 | 1 | 3 |
| Protein kinase C theta type | 0 | 1 | 1 | 2 |
| Protein kinase C zeta type | 0 | 1 | 1 | 2 |
| Protein kinase C delta type | 0 | 2 | 1 | 3 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
| Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 2 | 1 | 3 |
| Serine/threonine-protein kinase D1 | 0 | 1 | 1 | 2 |
| Estrogen receptor beta | 0 | 0 | 1 | 2 |
| Protein kinase C eta type | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Emopamil-binding protein-like | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
| 7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
| Protein kinase C theta type | 0 | 1 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| Luciferin 4-monooxygenase | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Ras guanyl-releasing protein 3 | 0 | 0 | 1 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |